144 related articles for article (PubMed ID: 9280216)
1. Does high-dose chemotherapy have a defined role in the treatment of solid tumors in 1997?
Weaver CH; Snyder MJ; Nichols WC
Semin Oncol; 1997 Aug; 24(4):xxxi, xxxvii-xxxviii. PubMed ID: 9280216
[No Abstract] [Full Text] [Related]
2. High-dose chemotherapy with autologous hematopoietic stem cell support for solid tumors in adults.
Pedrazzoli P; Rosti G; Secondino S; Carminati O; Demirer T; ; ;
Semin Hematol; 2007 Oct; 44(4):286-95. PubMed ID: 17961729
[TBL] [Abstract][Full Text] [Related]
3. High-dose chemotherapy and autologous hematopoietic stem cell transplantation for metastatic breast cancer: a therapy whose time has passed.
Vogl DT; Stadtmauer EA
Bone Marrow Transplant; 2006 Jun; 37(11):985-7. PubMed ID: 16708060
[No Abstract] [Full Text] [Related]
4. [Studies with high-dose chemotherapy and subsequent autologous stem cell transplantation in breast carcinoma].
Nitz U; Adomeit A; Mohrmann S; Fossari A; Frick M
Praxis (Bern 1994); 1998 Apr; 87(17):578-83. PubMed ID: 9623324
[TBL] [Abstract][Full Text] [Related]
5. Occult tumor cells detected in autologous blood stem cell harvests have no impact on 5 year outcomes for breast cancer patients with 4-9 positive nodes treated with adjuvant high-dose therapy and stem cell transplantation.
Reed E; Kessinger A; Murphy B; Tarantolo S; Traystman M; Sharp JG
Bone Marrow Transplant; 2003 Apr; 31(7):571-4. PubMed ID: 12692623
[TBL] [Abstract][Full Text] [Related]
6. High-dose chemotherapy for malignancies: a review.
Roman-Unfer S; Bitran JD
Compr Ther; 1996 Feb; 22(2):107-20. PubMed ID: 8689864
[No Abstract] [Full Text] [Related]
7. The sound and the fury: an update on the role of high-dose chemotherapy and autologous stem cell salvage for both metastatic and high-risk breast cancer.
Bar MH
Conn Med; 2000 Jan; 64(1):3-6. PubMed ID: 10697358
[No Abstract] [Full Text] [Related]
8. High-dose chemotherapy consolidation with autologous stem cell rescue in metastatic breast cancer: a 10-year experience.
Laport GF; Grad G; Grinblatt DL; Bitran JD; Williams SF
Bone Marrow Transplant; 1998 Jan; 21(2):127-32. PubMed ID: 9489628
[TBL] [Abstract][Full Text] [Related]
9. High-dose therapy in breast cancer: out of favor but not out of promise.
Glück S; Stewart D
Bone Marrow Transplant; 2000 May; 25(10):1017-9. PubMed ID: 10828859
[TBL] [Abstract][Full Text] [Related]
10. Dose intensive therapy in breast cancer.
Antman K; Corringham R; de Vries E; Elfenbein G; Gianni AM; Gisselbrecht C; Herzig R; Juttner C; Kaizer H; Kennedy MJ
Bone Marrow Transplant; 1992; 10 Suppl 1():67-73. PubMed ID: 1355686
[No Abstract] [Full Text] [Related]
11. HER-2/neu overexpression as a poor prognostic factor for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous stem cell transplantation.
Kim YS; Konoplev SN; Montemurro F; Hoy E; Smith TL; Rondón G; Champlin RE; Sahin AA; Ueno NT
Clin Cancer Res; 2001 Dec; 7(12):4008-12. PubMed ID: 11751494
[TBL] [Abstract][Full Text] [Related]
12. End of high-dose chemotherapy for high-risk breast cancer patients?
Tuma RS
J Natl Cancer Inst; 2008 May; 100(9):618-9. PubMed ID: 18445811
[No Abstract] [Full Text] [Related]
13. High-dose chemotherapy with autologous stem cell transplantation in patients with oligometastatic breast cancer.
Bojko P; Welt A; Schleucher R; Borquez D; Scheulen ME; Vanhoefer U; Poettgen C; Stuschke M; Broelsch CE; Stamatis G; Wilke H; Seeber S; Harstrick A
Bone Marrow Transplant; 2004 Oct; 34(7):637-43. PubMed ID: 15300229
[TBL] [Abstract][Full Text] [Related]
14. [High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy in primary breast cancer. An analysis of a systematic Cochrane review].
Nielsen DL; Svane IM
Ugeskr Laeger; 2004 Nov; 166(46):4148-50. PubMed ID: 15565849
[No Abstract] [Full Text] [Related]
15. Successive double high-dose chemotherapy with peripheral blood stem cell rescue collected during a single leukapheresis round in patients with high-risk pediatric solid tumors: a pilot study in a single center.
Sung KW; Yoo KH; Chung EH; Jung HL; Koo HH; Shin HJ; Lee SK; Lim DH; Kim DW; Park HK; Cho EJ; Kim SW
Bone Marrow Transplant; 2003 Mar; 31(6):447-52. PubMed ID: 12665839
[TBL] [Abstract][Full Text] [Related]
16. [High dose chemotherapy versus conventional chemotherapy in metastasing breast cancer. An analysis of a systematic Cochrane review].
Nielsen DL; Svane IM
Ugeskr Laeger; 2004 Nov; 166(46):4145-7. PubMed ID: 15565848
[No Abstract] [Full Text] [Related]
17. [High-dose chemotherapy with autologous bone marrow transplantation: 11 years' experience in Zurich].
Jost LM; Honegger HP; Stahel RA
Schweiz Med Wochenschr; 2000 Jan; 130(3):60-9. PubMed ID: 10683881
[TBL] [Abstract][Full Text] [Related]
18. Acute and late toxicity following adjuvant high-dose chemotherapy for high-risk primary operable breast cancer--a quality assessment study.
Svane IM; Homburg KM; Kamby C; Nielsen DL; Roer O; Sliffsgaard D; Johnsen HE; Hansen SW
Acta Oncol; 2002; 41(7-8):675-83. PubMed ID: 14651213
[TBL] [Abstract][Full Text] [Related]
19. Autologous peripheral blood stem cell transplantation in the patients with hematologic malignancies and solid tumors.
Ke X; Yang Y; Zhao X; Wang L
Chin Med J (Engl); 2001 Feb; 114(2):196-9. PubMed ID: 11780206
[TBL] [Abstract][Full Text] [Related]
20. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.
Steingrimsdottir H; Gruber A; Björkholm M; Svensson A; Hansson M
Haematologica; 2000 Aug; 85(8):832-8. PubMed ID: 10942930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
